Myocardial Infarction in the Young: A Retrospective Clinical Registry Study
- Disease/Condition
- Myocardial Infarction
- Study type
- Observational
- Intervention type
- diagnostic test
- Primary sponsor
- Western Sydney Local Health District
- Funder
- NSW Health;; National Heart Foundation of Australia
- Location
- Australia
- Phase
- Not Applicable
- Start date
- Aug 07, 2023
- End date
- Jul 31, 2027
Major adverse cardiovascular and Cerebrovascular events (MACCE) and all-cause of death
Myocardial infarction (MI) affects ~57,000 Australians every year and almost half a million Australians have had a heart attack at some point in their lives. While mortality after MI has been declining over the last few decades, it is in the group of young patients that it has lagged. Data on the biological and pathophysiological factors related to MI in the young is scarce. In addition, there are gaps in quality of care due to the perceived risk for MI being low. The study aims to characterise the clinical presentation, risk factors, angiography findings, underlying aetiology, quality of care and sex differences, of young patients with MI (age <50 years). This is an investigator-initiated, observational, single-centre clinical registry study. Approximately 500 patients under the age of 50 years with MI will be recruited retrospectively from Westmead Hospital.
- Registry
- Australian New Zealand Clinical Trials Registry
- Trial ID
- ANZCTR12623001097639
- Type
- Non-Device Trial
Access comprehensive clinical trial information for ANZCTR12623001097639 through Pure Global AI's free database. This Not Applicable trial is sponsored by Western Sydney Local Health District and is currently Recruiting. The study focuses on Myocardial Infarction.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.